Provention bio to present at the oppenheimer fall healthcare life sciences and medtech summit

Red bank, n.j., sept. 16, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the oppenheimer fall healthcare life sciences and medtech summit on wednesday, september 22, 2021 at 9:05 am e.t.
PRVB Ratings Summary
PRVB Quant Ranking